BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2019 9:57:12 AM | Browse: 907 | Download: 1922
 |
Received |
|
2018-11-05 02:52 |
|
Peer-Review Started |
|
2018-11-05 09:29 |
|
To Make the First Decision |
|
2018-12-29 01:04 |
|
Return for Revision |
|
2018-12-29 02:20 |
|
Revised |
|
2019-01-11 15:17 |
|
Second Decision |
|
2019-01-18 11:26 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-01-18 23:03 |
|
Articles in Press |
|
2019-01-18 23:03 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-01-24 08:40 |
|
Typeset the Manuscript |
|
2019-02-13 09:41 |
|
Publish the Manuscript Online |
|
2019-02-14 09:57 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hao Luo, Xia-Xia Zhang, Li-Hua Cao, Ning Tan, Qian Kang, Hong-Li Xi, Min Yu and Xiao-Yuan Xu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the 13th Five-Year Plan |
2018ZX09206005-002 |
|
| Corresponding Author |
Xiao-Yuan Xu, MD, Professor, Department of Infectious Diseases, Peking University First Hospital, Xishiku Street 8, Beijing 100034, China. xiaoyuanxu6@163.com |
| Key Words |
Chronic hepatitis B; Hepatitis B virus RNA; Virological response; HBeAg seroconversion; Entecavir |
| Core Tip |
HBeAg seroconversion was more likely to be achieved for chronic hepatitis B patients with hepatitis B virus (HBV) RNA levels below 4.12 log10 copies/mL before treatment. In the partial virological response group, serum HBV RNA showed an increasing trend. |
| Publish Date |
2019-02-14 09:57 |
| Citation |
Luo H, Zhang XX, Cao LH, Tan N, Kang Q, Xi HL, Yu M, Xu XY. Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients. World J Gastroenterol 2019; 25(6): 719-728 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i6/719.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i6.719 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
